Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 447
ORIGINAL ARTICLE
Year : 2013  |  Volume : 5  |  Issue : 3  |  Page : 191-194

New guidelines for diagnosis of gestational diabetes: Pathology-based impact assessment


1 Charles Darwin University, NT; NSW Health Pathology, NSW, Australia
2 Charles Sturt University, NSW, Australia
3 NSW Health Pathology, NSW, Australia

Correspondence Address:
Ezekiel Uba Nwose
School of Psychological and Clinical Sciences, Casuarina Campus, Yellow 2.2.58, Charles Darwin University, NT 0909
Australia
Login to access the Email id

Source of Support: Management of South West Pathology Service of NSW Health Australia., Conflict of Interest: None


DOI: 10.4103/1947-2714.109184

Rights and Permissions

Background: A recent study indicated an average of 19.5% abnormal oral glucose tolerance in antenatal clients per year. Aim: The purpose of this study was to determine the impact on gestational diabetes cases due to new guidelines for diagnosis and classification of hyperglycaemia in pregnancy. Materials and Methods: This study reviewed the archived clinical pathology data on oral glucose tolerance tests performed between January 1999 and December 2008 on antenatal clients ( N = 615). The cases were reviewed to determine changes if any in percentage of gestational diabetes due to new guidelines. Results: Over the 10 years period, a yearly average of additional 10.8% antenatal cases suggestive of gestational diabetes was observed due to the new recommended thresholds. Further, the average yearly incidence would have increased from 8.8 cases to 16.2 cases, which translates to almost 46% increase in the prospective numbers of gestational diabetes. Conclusions: This report presents the extent of how the new recommended guidelines for diagnosis and classification of hyperglycaemia in pregnancy could increase the prevalence of gestational diabetes. It also provides pathology-based evidence for the epidemiology of gestational diabetes mellitus and allows for planning the costs that would be attendant to the full implementation of the new guidelines.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1690    
    Printed65    
    Emailed0    
    PDF Downloaded392    
    Comments [Add]    
    Cited by others 5    

Recommend this journal